[Is hypolipemic treatment effective as a preventive measure?].
作者信息
Rywik S
出版信息
Przegl Lek. 1989;46(7):619-23.
PMID:2685917
Abstract
摘要
相似文献
1
[Is hypolipemic treatment effective as a preventive measure?].
Przegl Lek. 1989;46(7):619-23.
2
[Primary prevention of coronary disease by modification of the lipids].
Dtsch Med Wochenschr. 1984 Jun 15;109(24):965-7.
3
[Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
Nouv Presse Med. 1979 Mar 31;8(15):1223-5.
4
Artery magic.
US News World Rep. 2003 Nov 17;135(17):60-1.
5
[Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Lakartidningen. 1974 Sep 4;71(36):3289-91.
6
[Treatment of high blood cholesterol in patients with coronary heart disease].
Nihon Rinsho. 2003 Apr;61 Suppl 4:675-81.
7
[PATE Study [Pravastatin anti-Atherosclerosis Trial in the Elderly Study]].
Nihon Rinsho. 2001 Mar;59 Suppl 3:453-61.
8
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Monogr Atheroscler. 1985;13:74-84.
9
[Ezetimib].
Dtsch Med Wochenschr. 2004 Sep 24;129(39):2038-40. doi: 10.1055/s-2004-831843.
10
[The cholesterol question. Disinformed information].
G Ital Cardiol. 1991 Sep;21(9):1029-33.
Zotero 插件